Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Goebell

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Urologic Oncology|December 3, 2014
Current concepts--future needs: the 10th Annual Meeting of the International Bladder Cancer Network (IBCN) in Nijmegen, The Netherlands, September 20th to 22nd, 2012Roman Nawroth, Peter J Goebell, Ashish M Kamat, et al.
Urologic Oncology|March 18, 2018
Editorial: Managing locally advanced bladder cancer. Third International Bladder Cancer Network seminars seriesPeter C Black, Peter J Goebell, Ashish M Kamat, et al.
BMC Cancer|June 5, 2015
Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experienceMargitta Retz, Patrick de Geeter, Peter J Goebell, et al.
Future Oncology (London, England)|May 20, 2017
The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscapePeter J Goebell, Christian Doehn, Carsten Grüllich, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
New Horizons in Bladder Cancer Research: Report of the 15th Meeting of the International Bladder Cancer Network (IBCN) in Lisbon, Portugal, October 21-23, 2017Peter C Black, Peter J Goebell, Ashish M Kamat, et al.
Urologic Oncology|February 22, 2025
Change of the guards-Looking back at Michael Droller: Visionary and supporter-The perspective of the International Bladder Cancer NetworkBernd J Schmitz-Dräger, H Barton Grossmann, Peter J Goebell, et al.
Aktuelle Urologie|September 25, 2023
[Geriatric assessment - What should be done and considered before starting therapy of mHSPC and mCRPC?]Hendrik Heers, Marius Cristian Butea-Bocu, Christer Groeben, et al.
Urologic Oncology|September 24, 2016
Taking the next step-Advancing bladder cancer managementAntonia Vlahou, Peter C Black, Peter J Goebell, et al.
Urologia Internationalis|February 10, 2022
Analysis of the Impact of Clinical Factors on Low-Intensity Extracorporeal Shockwave Therapy for Erectile DysfunctionNatalie Oginski, Hendrik Apel, Mario Richterstetter, et al.
Clinical Genitourinary Cancer|October 11, 2016
Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials-Analyses From the German Clinical RCC RegistryNorbert Marschner, Michael Staehler, Lothar Müller, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Urologic Oncology|December 3, 2014
Current concepts--future needs: the 10th Annual Meeting of the International Bladder Cancer Network (IBCN) in Nijmegen, The Netherlands, September 20th to 22nd, 2012Roman Nawroth, Peter J Goebell, Ashish M Kamat, et al.
Urologic Oncology|March 18, 2018
Editorial: Managing locally advanced bladder cancer. Third International Bladder Cancer Network seminars seriesPeter C Black, Peter J Goebell, Ashish M Kamat, et al.
BMC Cancer|June 5, 2015
Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experienceMargitta Retz, Patrick de Geeter, Peter J Goebell, et al.
Future Oncology (London, England)|May 20, 2017
The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscapePeter J Goebell, Christian Doehn, Carsten Grüllich, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
New Horizons in Bladder Cancer Research: Report of the 15th Meeting of the International Bladder Cancer Network (IBCN) in Lisbon, Portugal, October 21-23, 2017Peter C Black, Peter J Goebell, Ashish M Kamat, et al.
Urologic Oncology|February 22, 2025
Change of the guards-Looking back at Michael Droller: Visionary and supporter-The perspective of the International Bladder Cancer NetworkBernd J Schmitz-Dräger, H Barton Grossmann, Peter J Goebell, et al.
Aktuelle Urologie|September 25, 2023
[Geriatric assessment - What should be done and considered before starting therapy of mHSPC and mCRPC?]Hendrik Heers, Marius Cristian Butea-Bocu, Christer Groeben, et al.
Urologic Oncology|September 24, 2016
Taking the next step-Advancing bladder cancer managementAntonia Vlahou, Peter C Black, Peter J Goebell, et al.
Urologia Internationalis|February 10, 2022
Analysis of the Impact of Clinical Factors on Low-Intensity Extracorporeal Shockwave Therapy for Erectile DysfunctionNatalie Oginski, Hendrik Apel, Mario Richterstetter, et al.
Clinical Genitourinary Cancer|October 11, 2016
Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials-Analyses From the German Clinical RCC RegistryNorbert Marschner, Michael Staehler, Lothar Müller, et al.
Pageof 11